Tulaven

How to use

Subcutaneous use in cattle, intramuscular in sheep and pigs
• one single shot: 1 mL/40kg

Withdrawal (meat and offal): 22 days (cattle), 16 days (sheep), 13 days

Prescription decisions are for the person issuing the prescription alone. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet at www.noahcomendium.co.uk or on request.

Legal Category: UK POMV

SPC

Why choose
Tulaven?

Broad spectrum

Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis

Long duration of action

Persists above the MIC in tissues, enabling: 15 days of coverage for P. multocida; 15 days for H. somni and 9 days for M. haemolytica^1,2

Low dose volume

Cattle: 1 ml/40 kg bodyweight

Sheep: 1 ml/40 kg bodyweight

Ovine foot rot

Licenced for the treatment of the early stages of infectious pododermatitis (foot rot) in sheep

Pink eye

Licenced for the treatment of this infectious common ocular disease of cattle, caused by Moraxella bovis

Hi-tech CLAS vial

Shock resistant³, eco-friendly ⁴, easier handling vials

References

Nowakowski, M.A., Inskeep, P.B., Risk, J.E., Skogerboe, T.L., Benchaoui, H.A., Meinert, T.R., Sherington, J., Sunderland, S.J., 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet. Ther. 5, 60–74.
Godinho, K.S., Keane, S.G., Nanjiani, I.A., Benchaoui, H.A., Sunderland, S.J., Jones, M.A., Weatherley, A.J., Gootz, T.D., Rowan, T.G., 2005. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet. Ther. 6, 113–121
Cavaroc P. J. et al. Comparative breakage study of injectable anti-infectives vials under vertical drop test by free fall under standardized conditions. IPVS Congress, 2012, 100
Jacquet C. et al. Comparative life cycle analysis, final report with critical review, CLAS packaging system and traditional glass packaging system. 2016, APESA 0393 Impact 2002 fig 18 p33, fig.21 p36

Nowakowski, M.A., Inskeep, P.B., Risk, J.E., Skogerboe, T.L., Benchaoui, H.A., Meinert, T.R., Sherington, J., Sunderland, S.J., 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triam ...

Nowakowski, M.A., Inskeep, P.B., Risk, J.E., Skogerboe, T.L., Benchaoui, H.A., Meinert, T.R., Sherington, J., Sunderland, S.J., 2004. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet. Ther. 5, 60–74.
Godinho, K.S., Keane, S.G., Nanjiani, I.A., Benchaoui, H.A., Sunderland, S.J., Jones, M.A., Weatherley, A.J., Gootz, T.D., Rowan, T.G., 2005. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology. Vet. Ther. 6, 113–121
Cavaroc P. J. et al. Comparative breakage study of injectable anti-infectives vials under vertical drop test by free fall under standardized conditions. IPVS Congress, 2012, 100
Jacquet C. et al. Comparative life cycle analysis, final report with critical review, CLAS packaging system and traditional glass packaging system. 2016, APESA 0393 Impact 2002 fig 18 p33, fig.21 p36

How to use

Why choose Tulaven?

References

Why choose
Tulaven?